PlainRecalls
FDA Drug Low Class III Terminated

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.

Reported: December 31, 2014 Initiated: November 25, 2014 #D-0313-2015

Product Description

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.

Reason for Recall

Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.

Details

Recalling Firm
Hospira Inc.
Units Affected
3,306 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.. Recalled by Hospira Inc.. Units affected: 3,306 vials.
Why was this product recalled?
Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 31, 2014. Severity: Low. Recall number: D-0313-2015.